These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7138588)

  • 41. An assessment of platelet aggregation induced by 5-hydroxytryptamine.
    Hilton BP; Cumings JN
    J Clin Pathol; 1971 Apr; 24(3):250-8. PubMed ID: 5573439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine.
    Buus Lassen J; Lund J; Bechgaard E; Søndergaard I
    Psychopharmacology (Berl); 1979 Aug; 64(2):149-53. PubMed ID: 115034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?
    Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S120-2. PubMed ID: 2412031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation by serotonin of 40 kDa and 20 kDa protein phosphorylation in human platelets.
    de Chaffoy de Courcelles D; Roevens P; van Belle H
    FEBS Lett; 1984 Jun; 171(2):289-92. PubMed ID: 6233173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidepressants and the serotonin uptake in platelets.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1980; 280():111-9. PubMed ID: 6996427
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibitory effect of ketanserin on ergonovine-induced contractions of isolated canine coronary arteries.
    Van Beek J; Janssen PA; Van Nueten JM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):167-71. PubMed ID: 6651401
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: more complicated than previously thought.
    Lingjaerde O
    Psychopharmacology (Berl); 1979 Mar; 61(3):245-9. PubMed ID: 109887
    [No Abstract]   [Full Text] [Related]  

  • 48. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
    Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ketanserin on platelet function and red cell filterability in hypertension and peripheral vascular disease.
    Zannad F; Voisin P; Pointel JP; Schmitt C; Freitag B; Stoltz JF
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S32-4. PubMed ID: 2412053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of ketanserin on hemostasis in vitro.
    Bergqvist D; Arvidsson S; Haglund U; Hedner U; Lindblad B
    Thromb Res; 1986 Jul; 43(2):237-41. PubMed ID: 2943051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggregation of duck thrombocytes by 5-hydroxytryptamine.
    Belamarich FA; Simoneit LW
    Microvasc Res; 1973 Sep; 6(2):229-34. PubMed ID: 4748022
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-hydroxytryptamine and precapillary vessels.
    Van Nueten JM
    Fed Proc; 1983 Feb; 42(2):223-7. PubMed ID: 6295823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    McGoon MD; Vanhoutte PM
    J Clin Invest; 1984 Sep; 74(3):828-33. PubMed ID: 6470141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketanserin and vascular contractions in response to cooling.
    Van Nueten JM; De Ridder W; Vanhoutte PM
    Eur J Pharmacol; 1984 Apr; 99(4):329-32. PubMed ID: 6734731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists.
    Kiefel JM; Paul D; Bodnar RJ
    Brain Res; 1989 Oct; 500(1-2):231-40. PubMed ID: 2605492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of platelet-derived contractile agents on human digital arteries.
    Moulds RF; Iwanov V; Medcalf RL
    Clin Sci (Lond); 1984 Apr; 66(4):443-51. PubMed ID: 6697664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of rhythmic swimming activity in post-embryonic Xenopus laevis tadpoles by 5-hydroxytryptamine acting at 5HT1a receptors.
    Wedderburn JF; Sillar KT
    Proc Biol Sci; 1994 Jul; 257(1348):59-66. PubMed ID: 8090792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.